Small intestinal sulphoxidation of Albendazole

References

• Cook G. C. Use of benzimidazole chemotherapy in human helminthiases: indications and efficacy. Parasitology Today 1990; 6: 133–137
   PubMedGoogle Scholar
• Dawson J. R., Schwenk M. Isolated epithelial cells. Progress in Pharmacology and Clinical Pharmacology 1989; 7: 21–41
   Google Scholar
• Delatour P., Benoit F., Garnier F., Besse S. Chirality of the sulphoxide metabolites of fenbendazole and Albendazole in sheep. Journal of Veterinary Pharmacology and Therapeutics 1990; 13: 361–366
   PubMed Web of Science ®Google Scholar
• Dubey R. K., Singh J. Localization and characterization of drug metabolizing enzymes along the villus-crypt surface of the rat small intestine. I. Biochemical Pharmacology 1988; 37: 169–176
   PubMed Web of Science ®Google Scholar
• Fargetton X., Galtier P., Delatour P. Sulfoxidation of Albendazole by a cytochrome p450-independent monooxigenase from rat liver microsomes. Veterinary Research Communications 1986; 10: 317–324
   PubMed Web of Science ®Google Scholar
• Friedberg T., Siegert P., Grassow M. A., Bartlomowicz B., Oesch F. Studies of the expression of the cytochrome P450IA, P450IIB, and P450IIC gene family in extrahepatic and hepatic tissues. Environmental Health Perspectives 1990; 88: 67–90
   PubMed Web of Science ®Google Scholar
• Galtier P., Alvinerie M. S., Delatour P. In vitro sulfoxidation of Albendazole by ovine liver microsomes: assay and frequency of various xenobiotics. American Journal of Veterinary Research 1986; 47: 447–450
   PubMed Web of Science ®Google Scholar
• Galtier P., Alvinerie M., Steimer J. L., Francheteau P., Plusquellec Y., Houin G. Simultaneous pharmacokinetic modeling of a drug and two metabolites: application to Albendazole in sheep. Journal of Pharmaceutical Sciences 1991; 80: 3–10
   PubMed Web of Science ®Google Scholar
• Gil-Grande L. A., Rodriguez-Caabeiro F., Prieto J. G., Sanchez Ruano J. J., Brasa C., et al. Randomised controlled trial of efficacy of albendazole in intra-abdominal hydatid disease. Lancet 1993; 342: 1269–1272
   PubMed Web of Science ®Google Scholar
• Gottschall D. W., Thedorides V. J., Wang R. The metabolism of benzimidazole anthelmintics. Parasitology Today 1990; 6: 118–124
   Google Scholar
• Harmsworth W. L., Franklin M. R. Induction of hepatic and extrahepatic cytochrome P-450 and monooxigenase activities by N-substituted imidazoles. Xenobiotica 1990; 20: 1053–1063
   PubMed Web of Science ®Google Scholar
• Kaminsky L. S., Fasco M. J. Small intestinal cytochromes P450. Critical Reviews in Toxicology 1992; 21: 407–422
   Web of Science ®Google Scholar
• Klee S., Langen B., Galtier P., Ungemach F. R. Studies on intestinal cytochrome P450 isozymes in rats, guinea-pigs and pigs. Proceedings of the Sixth International Congress of Veterinary Pharmacology and Toxicology. Blackwell, Oxford 1994; 36
   Google Scholar
• Kolars J. C., Awni W. N., Merion R. M. First-pass metabolism of cyclosporin by the gut. Lancet 1991; 338: 1488–1490
   PubMed Web of Science ®Google Scholar
• Lanusse C., Nare B., Gascon L. H., Prichard R. K. Metabolism of Albendazole and Albendazole sulphoxide by ruminal and intestinal fluids of sheep and cattle. Xenobiotica 1992; 22: 419–426
   PubMed Web of Science ®Google Scholar
• Lanusse C. E., Prichard R. K. Clinical pharmacokinetics and metabolism of benzimidazole anthelmintics in ruminants. Drug Metabolism Reviews 1993; 25: 235–279
   PubMed Web of Science ®Google Scholar
• Lanusse C. E., Nare B., Prichard R. K. Comparative sulphoxidation of Albendazole by sheep and cattle liver microsomes and the inhibitory effect of methimazole. Xenobiotica 1993; 23: 285–295
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with Folin reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Murray M., Hudson A. M., Yassa V. Hepatic microsomal metabolism of the anthelmintic benzimidazole Fenbendazole: enhanced inhibition of cytochrome P450 reactions by oxidized metabolites of the drug. Chemical Research in Toxicology 1992; 5: 60–66
   PubMed Web of Science ®Google Scholar
• Rolin S., Souhaili-El Amri H., Batt A. M. Study of the in vitro bioactivation of Albendazole in human liver microsomes and hepatoma cell lines. Cell Biology and Toxicology 1989; 5: 1–14
   PubMed Web of Science ®Google Scholar
• Shirkey R. J., Chakraborty J., Bridges J. W. An improved method for preparing rat small intestine microsomal fractions for studying drug metabolism. Analytical Biochemistry 1979; 93: 73–81
   PubMed Web of Science ®Google Scholar
• Short C. R., Flory W., Hsieh L. C., Barker S. A. The oxidative metabolism of fenbendazole: a comparative study. Journal of Veterinary Pharmacology and Therapeutics 1988; 11: 50–55
   PubMed Web of Science ®Google Scholar
• Souhaili-El Amri H., Fargetton X., Delatour P., Batt A. M. Sulfoxidation of Albendazole by the FAD-containing and cytochrome P-450 dependent mono-oxigenases from pig liver microsomes. Xenobiotica 1987; 17: 1159–1168
   PubMed Web of Science ®Google Scholar
• Souhaili-El Amri H., Fargetton X., Benoit E., Totis M., Batt A. M. Inducing effect of Albendazole on rat liver drug-metabolizing enzymes and metabolite pharmacokinetics. Toxicology and Applied Pharmacology 1988a; 92: 141–149
   PubMed Web of Science ®Google Scholar
• Souhaili-El Amri H., Mothe O., Totis M., Masson C., Batt A. M., Delatour P., Siest G. Albendazole sulfonation by rat liver cytochrome P-450c. Journal of Pharmacology and Experimental Therapeutics 1988b; 246: 758–764
   PubMed Web of Science ®Google Scholar
• Steiger U., Cotting J., Reichen J. Albendazole treatment of echinococcosis in humans: effects on microsomal metabolism and drug tolerance. Clinical Pharmacology and Therapeutics 1990; 47: 347–353
   PubMed Web of Science ®Google Scholar
• Tynes R. E., Hodgson E. Oxidation of Thiobenzamide by the FAD containing and cytochrome P-450 dependent monooxygenases of liver and lung microsomes. Biochemical Pharmacology 1983; 32: 3419–3428
   PubMed Web of Science ®Google Scholar
• Villaverde C., Alvarez A. I., Del Estal J. L., Prieto J. G. Albendazole and Mebendazole uptake by isolated enterocytes. Developmental Pharmacology and Therapeutics 1992; 19: 27–31
   PubMedGoogle Scholar
• Watkins P. B. Drug metabolism by cytochromes P450 in the liver and small bowel. Gastrointestinal Pharmacology 1992; 21: 511–526
   Google Scholar